These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34484125)

  • 1. Biased Coupling to β-Arrestin of Two Common Variants of the CB
    Turu G; Soltész-Katona E; Tóth AD; Juhász C; Cserző M; Misák Á; Balla A; Caron MG; Hunyady L
    Front Endocrinol (Lausanne); 2021; 12():714561. PubMed ID: 34484125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors.
    Soethoudt M; van Gils N; van der Stelt M; Heitman LH
    Methods Mol Biol; 2016; 1412():103-11. PubMed ID: 27245896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
    Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
    J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retromer stops beta-arrestin 1-mediated signaling from internalized cannabinoid 2 receptors.
    Nogueras-Ortiz C; Roman-Vendrell C; Mateo-Semidey GE; Liao YH; Kendall DA; Yudowski GA
    Mol Biol Cell; 2017 Nov; 28(24):3554-3561. PubMed ID: 28954865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of β-arrestin-2 and clathrin in agonist-mediated internalization of the human cannabinoid CB2 receptor.
    Chen X; Zheng C; Qian J; Sutton SW; Wang Z; Lv J; Liu C; Zhou N
    Curr Mol Pharmacol; 2014; 7(1):67-80. PubMed ID: 25023974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineating the interactions between the cannabinoid CB
    Patel M; Matti C; Grimsey NL; Legler DF; Javitch JA; Finlay DB; Glass M
    Br J Pharmacol; 2022 May; 179(10):2223-2239. PubMed ID: 34811740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-protein receptor kinase 5 regulates the cannabinoid receptor 2-induced up-regulation of serotonin 2A receptors.
    Franklin JM; Carrasco GA
    J Biol Chem; 2013 May; 288(22):15712-24. PubMed ID: 23592773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol skews biased agonism at cannabinoid CB
    Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
    Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular Assay to Study β-Arrestin Recruitment by the Cannabinoid Receptors 1 and 2.
    Bouma J; Soethoudt M; van Gils N; Xia L; van der Stelt M; Heitman LH
    Methods Mol Biol; 2023; 2576():189-199. PubMed ID: 36152187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing cannabinoid CB2 receptor ligands using DiscoveRx PathHunter beta-arrestin assay.
    McGuinness D; Malikzay A; Visconti R; Lin K; Bayne M; Monsma F; Lunn CA
    J Biomol Screen; 2009 Jan; 14(1):49-58. PubMed ID: 19171920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β
    Choi M; Staus DP; Wingler LM; Ahn S; Pani B; Capel WD; Lefkowitz RJ
    Sci Signal; 2018 Aug; 11(544):. PubMed ID: 30131371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists.
    Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M
    Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor.
    Carrasquer A; Nebane NM; Williams WM; Song ZH
    Pharmacogenet Genomics; 2010 Mar; 20(3):157-66. PubMed ID: 20124950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging strategies targeting CB
    Morales P; Goya P; Jagerovic N
    Biochem Pharmacol; 2018 Nov; 157():8-17. PubMed ID: 30055149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Variant Q63R of Cannabinoid Receptor 2 Causes Differential ERK Phosphorylation in Human Immune Cells.
    Wang J; Xu J; Liu J; Zhu H; Peng Y; Ding ZM; Hua H
    Genet Test Mol Biomarkers; 2018 May; 22(5):320-326. PubMed ID: 29694791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biased signaling in naturally occurring mutations of G protein-coupled receptors associated with diverse human diseases.
    Yang LK; Hou ZS; Tao YX
    Biochim Biophys Acta Mol Basis Dis; 2021 Jan; 1867(1):165973. PubMed ID: 32949766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the 'DRY' motif of the CB1 cannabinoid receptor result in biased receptor variants.
    Gyombolai P; Tóth AD; Tímár D; Turu G; Hunyady L
    J Mol Endocrinol; 2015 Feb; 54(1):75-89. PubMed ID: 25510402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin type 1A receptor regulates β-arrestin binding of the β
    Tóth AD; Gyombolai P; Szalai B; Várnai P; Turu G; Hunyady L
    Mol Cell Endocrinol; 2017 Feb; 442():113-124. PubMed ID: 27908837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cardiac fibrosis by β-blocker in G protein-independent and G protein-coupled receptor kinase 5/β-arrestin2-dependent Signaling pathways.
    Nakaya M; Chikura S; Watari K; Mizuno N; Mochinaga K; Mangmool S; Koyanagi S; Ohdo S; Sato Y; Ide T; Nishida M; Kurose H
    J Biol Chem; 2012 Oct; 287(42):35669-35677. PubMed ID: 22888001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.